Wallace Eli M. bought BBOT
January 1, 2026 · Form 4 insider transaction
Wallace Eli M. bought 1,114,400 shares of BridgeBio Oncology Therapeutics, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 4 days after the transaction.
Direction
Acquired (buy-side)
Shares
1,114,400
Price
$0.00
Total value
N/A
InsiderWallace Eli M.
RoleOfficer, Director
SecurityStock Option (Right to Buy)
Transaction codeA: Grant or award
Transaction dateJanuary 1, 2026
Filing dateJanuary 5, 2026
Shares owned after1,114,400
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
69,650 of the shares underlying the option vested on January 2, 2026. Thereafter, 1/48th of the shares underlying the option will vest monthly, with full vesting scheduled for October 2, 2029, subject to the Reporting Person's continuous service with the Issuer on each such vesting date.